ப்ரொஃபெஸர் பியோனா மரம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ப்ரொஃபெஸர் பியோனா மரம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ப்ரொஃபெஸர் பியோனா மரம் Today - Breaking & Trending Today

Pharmaxis Ltd has multiple potential value inflection points with two drugs advancing in clinical trials


Pharmaxis Ltd (ASX:PXS) (FRA:UUD) has multiple potential value inflection points over the next two years, with two drugs in clinical trials that are due to report meaningful efficacy and safety endpoints in patients by the end of 2022. 
The company has a platform technology that has delivered a pipeline of first in class or best in class clinical drugs for inflammatory and fibrotic diseases. The first of these drugs already has an IND approval from the FDA and is currently being trialled in myelofibrosis patients.
Its lead asset PXS-5505 – with disease-modifying potential in myelofibrosis – is in Phase 1c/2 trial, with further collaborations to extend the value of PXS-5505 in a variety of other oncology indications where there is strong unmet need. ....

New York , United States , Boston University , New South Wales , Frenchs Forest , Gary Phillips , Katya Ravid , School Of Biomedical Sciences Dr Kylie Sandy , Professor Of Biology At Boston University , Drug Administration , Boston University School Of Medicine , University Of Western Australia , Drugs Administration , Senior Research , Chiesi United States Inc , National Heart , Blood Institute , Neck Cancer , Professor Fiona Wood , Western Australia , Fiona Stanley Hospital , Research Fellow , Biomedical Sciences Dr Kylie Sandy , Boston University School , Professor Katya Ravid , Stem Cell ,

World-first trial for Australian company Pharmaxis


(ASX:PSX) has announced a partnership to launch a world-first clinical trial that aims to stop scars from forming after trauma, particularly following burn injuries.
The company is partnering with distinguished surgeon and burns expert Professor Fiona Wood AM who is leading a group of researchers from the University of Western Australia (UWA) and Fiona Stanley Hospital to test a treatment in the first human trials.
Pharmaxis said its discovery, known as PXS‐6302, has shown promising pre‐clinical results in inhibiting the enzymes that play a critical role in the development of scar tissue.
PXS‐6302 was discovered by the company’s researchers at its laboratories in Sydney. ....

New South Wales , Gary Phillips , Kylie Sandy , School Of Biomedical Sciences , University Of Western Australia , Professor Fiona Wood , Western Australia , Fiona Stanley Hospital , Biomedical Sciences , Biotechnology Industry , Senior Research Fellow , Research Fellow , Clinical Trial , Wound Healing , புதியது தெற்கு வேல்ஸ் , கேரி பிலிப்ஸ் , கைலி மணல் , பள்ளி ஆஃப் உயிர் மருத்துவ அறிவியல் , பல்கலைக்கழகம் ஆஃப் மேற்கு ஆஸ்திரேலியா , ப்ரொஃபெஸர் பியோனா மரம் , மேற்கு ஆஸ்திரேலியா , பியோனா ஸ்டான்லி மருத்துவமனை , உயிர் மருத்துவ அறிவியல் , உயிரி தொழில்நுட்பவியல் , உயிரி தொழில்நுட்பவியல் தொழில் , மூத்தவர் ஆராய்ச்சி சக ,